ProMIS Neurosciences Announces Board and Officer Changes
Ticker: PMN · Form: 8-K · Filed: 2024-10-10T00:00:00.000Z
Sentiment: neutral
Topics: management-change, board-of-directors, executive-compensation
TL;DR
ProMIS Neurosciences shakes up board and exec team, expect new comp plans.
AI Summary
ProMIS Neurosciences Inc. announced on October 8, 2024, changes in its board of directors and executive officers. The filing details the election of new directors and the appointment of certain officers, alongside information regarding compensatory arrangements for these individuals. The company, formerly known as Amorfix Life Sciences Ltd., is incorporated in Ontario, Canada.
Why It Matters
Changes in leadership and executive compensation can signal shifts in company strategy or financial priorities, impacting investor confidence and future performance.
Risk Assessment
Risk Level: medium — Changes in board and executive composition can indicate internal shifts or strategic realignments that may carry inherent risks.
Key Players & Entities
- ProMIS Neurosciences Inc. (company) — Registrant
- Amorfix Life Sciences Ltd. (company) — Former company name
- October 8, 2024 (date) — Date of earliest event reported
- Ontario, Canada (location) — Jurisdiction of incorporation
FAQ
What specific changes were made to the board of directors?
The filing indicates the election of directors, but the specific names and details of the changes are not provided in this excerpt.
Who were the newly appointed officers?
The filing mentions the appointment of certain officers but does not list their names or specific roles in this excerpt.
What are the details of the compensatory arrangements for the new officers and directors?
The filing notes that information regarding compensatory arrangements is included, but the specific details are not present in this provided text.
When did ProMIS Neurosciences Inc. change its name from Amorfix Life Sciences Ltd.?
The date of the name change from Amorfix Life Sciences Ltd. to ProMIS Neurosciences Inc. was August 31, 2006.
What is the primary business of ProMIS Neurosciences Inc.?
ProMIS Neurosciences Inc. is in the Pharmaceutical Preparations industry, SIC code 2834.
Filing Stats: 920 words · 4 min read · ~3 pages · Grade level 11.8 · Accepted 2024-10-10 16:42:37
Key Financial Figures
- $500,000 — providing for an annual base salary of $500,000 and annual discretionary bonus with a t
- $1.15 — tial Award and the Performance Award is $1.15 per share, the 5-day volume-weighted av
Filing Documents
- pmn-20241008x8k.htm (8-K) — 39KB
- pmn-20241008xex10d1.htm (EX-10.1) — 54KB
- pmn-20241008xex10d2.htm (EX-10.2) — 105KB
- 0001558370-24-013244.txt ( ) — 361KB
- pmn-20241008.xsd (EX-101.SCH) — 4KB
- pmn-20241008_def.xml (EX-101.DEF) — 3KB
- pmn-20241008_lab.xml (EX-101.LAB) — 17KB
- pmn-20241008_pre.xml (EX-101.PRE) — 12KB
- pmn-20241008x8k_htm.xml (XML) — 5KB
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 10.1 Employment Agreement with Neil Warma, dated October 8, 2024 10.2 Form of Indemnification Agreement 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. PROMIS NEUROSCIENCES INC. Date: October 10, 2024 By: /s/ Neil Warma Name: Neil Warma Title: Interim Chief Executive Officer